dpp 4 inhibitors vs glp 1 agonist DPP-4 and GLP-1RAs: cardiovascular safety and benefits glp-1 agonist dpp 4 inhibitor

Evaluation of exenatide versus insulin glargine for the impact on endothelial functions and cardiovascular risk markers

doi: 10.1185/030079908X253870 [DOI] [PubMed] [Google Scholar] 6

As some patients may perceive their medications as only those in pill form or to deal with an illness, they may fail to include their regular use of GLP-1 agonists as part of their history

These Phase 3 trials enrolled thousands of participants across multiple studies, providing robust evidence for efficacy and safety

Some GLP-1 and related medications are approved for chronic weight management in eligible adults without diabetes

Several different GLP-1 medications are approved specifically for weight loss, including Wegovy, Saxenda, and Zepbound